These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 19210287)

  • 1. Fibrinolysis-independent role of plasmin and its activators in the haematopoietic recovery after myeloablation.
    Tjwa M; Moura R; Moons L; Plaisance S; De Mol M; Jansen S; Dewerchin M; Verfaillie C; Carmeliet P
    J Cell Mol Med; 2009; 13(11-12):4587-95. PubMed ID: 19210287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
    Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
    EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
    Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tranexamic acid mediates proinflammatory and anti-inflammatory signaling via complement C5a regulation in a plasminogen activator-dependent manner.
    Barrett CD; Moore HB; Kong YW; Chapman MP; Sriram G; Lim D; Moore EE; Yaffe MB
    J Trauma Acute Care Surg; 2019 Jan; 86(1):101-107. PubMed ID: 30575685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo.
    Suelves M; López-Alemany R; Lluís F; Aniorte G; Serrano E; Parra M; Carmeliet P; Muñoz-Cánoves P
    Blood; 2002 Apr; 99(8):2835-44. PubMed ID: 11929773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen and plasmin activity in patients with coronary artery disease.
    Drinane MC; Sherman JA; Hall AE; Simons M; Mulligan-Kehoe MJ
    J Thromb Haemost; 2006 Jun; 4(6):1288-95. PubMed ID: 16706973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinolytic cross-talk: a new mechanism for plasmin formation.
    Dejouvencel T; Doeuvre L; Lacroix R; Plawinski L; Dignat-George F; Lijnen HR; Anglés-Cano E
    Blood; 2010 Mar; 115(10):2048-56. PubMed ID: 19996088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergy between a plasminogen cascade and MMP-9 in autoimmune disease.
    Liu Z; Li N; Diaz LA; Shipley M; Senior RM; Werb Z
    J Clin Invest; 2005 Apr; 115(4):879-87. PubMed ID: 15841177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myosin as cofactor and substrate in fibrinolysis.
    Machovich R; Ajtai K; Kolev K; Owen WG
    FEBS Lett; 1997 Apr; 407(1):93-6. PubMed ID: 9141488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of plasminogen activation protects against ganglion cell loss in a mouse model of retinal damage.
    Zhang X; Chaudhry A; Chintala SK
    Mol Vis; 2003 Jun; 9():238-48. PubMed ID: 12813409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin.
    Silverstein RL; Harpel PC; Nachman RL
    J Biol Chem; 1986 Jul; 261(21):9959-65. PubMed ID: 2942536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylokinase reduces plasmin formation by endogenous plasminogen activators.
    Jin T; Bokarewa M; Zhu Y; Tarkowski A
    Eur J Haematol; 2008 Jul; 81(1):8-17. PubMed ID: 18331597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasmin-dependent and -independent effects of plasminogen activators and inhibitor-1 on ex vivo angiogenesis.
    Brodsky S; Chen J; Lee A; Akassoglou K; Norman J; Goligorsky MS
    Am J Physiol Heart Circ Physiol; 2001 Oct; 281(4):H1784-92. PubMed ID: 11557572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolysis: the key to new pathogenetic mechanisms.
    Zorio E; Gilabert-Estellés J; España F; Ramón LA; Cosín R; Estellés A
    Curr Med Chem; 2008; 15(9):923-9. PubMed ID: 18473800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmin is not protective in experimental renal interstitial fibrosis.
    Edgtton KL; Gow RM; Kelly DJ; Carmeliet P; Kitching AR
    Kidney Int; 2004 Jul; 66(1):68-76. PubMed ID: 15200414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular matrix degradation by cultured mesangial cells: mediators and modulators.
    Baricos WH; Reed JC; Cortez SL
    Exp Biol Med (Maywood); 2003 Oct; 228(9):1018-22. PubMed ID: 14530509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue and urokinase plasminogen activators instigate the degeneration of retinal ganglion cells in a mouse model of glaucoma.
    Chintala SK
    Exp Eye Res; 2016 Feb; 143():17-27. PubMed ID: 26474495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrin alphaMbeta2 orchestrates and accelerates plasminogen activation and fibrinolysis by neutrophils.
    Pluskota E; Soloviev DA; Bdeir K; Cines DB; Plow EF
    J Biol Chem; 2004 Apr; 279(17):18063-72. PubMed ID: 14769799
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
    List K; Jensen ON; Bugge TH; Lund LR; Ploug M; Danø K; Behrendt N
    Biochemistry; 2000 Jan; 39(3):508-15. PubMed ID: 10642175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired clot lysis by rt-PA catalyzed mini-plasminogen activation.
    Duboscq C; Genoud V; Parborell MF; Kordich LC
    Thromb Res; 1997 Jun; 86(6):505-13. PubMed ID: 9219330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.